文献速递肝病胰腺与胆道疾病

简易磁共振评分与原发性硬化性胆管炎患者结局相关

Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-03-15

研究评估基于磁共振胆管成像的Anali评分对原发性硬化性胆管炎患者预后的预测价值,在法国119例内部队列及加拿大、意大利、英国119例外部队列中验证,发现Anali评分与无肝移植或肝硬化失代偿生存相关,内部队列c-statistic分别为0.89(不含钆)和0.75(含钆)。

要点

  • Anali评分由磁共振胆管成像的胆管扩张、形态异常和门脉高压等放射学因素计算。
  • 内部队列中Anali评分不含钆的c-statistic为0.89(95%CI 0.84-0.95),含钆为0.75(95%CI 0.64-0.87)。
  • 外部队列验证了Anali评分的预后价值,作者认为其可能作为预后因素使用。

核心结论

  • 在内部和外部队列中,基于磁共振胆管成像计算的Anali评分与原发性硬化性胆管炎患者结局相关,可能作为预后因素。

研究设计与样本

  • 回顾性研究,纳入大导管型原发性硬化性胆管炎患者,内部队列119例(法国),外部队列119例(加拿大、意大利和英国)。
  • 所有首次可获得的磁共振胆管成像结果由2名放射科医生审阅并计算Anali评分。
  • 主要终点为无肝移植或肝硬化失代偿的生存,采用Cox回归模型评估预后价值。

主要发现

  • 内部队列总随访549患者年,记录2例肝移植、4例肝相关死亡、26例肝硬化失代偿;外部队列总随访497患者年,记录8例肝移植、3例肝相关死亡、25例肝硬化失代偿。
  • 内部队列单因素分析中,与无肝移植或肝硬化失代偿生存相关的因素包括血清胆红素、天冬氨酸氨基转移酶、丙氨酸氨基转移酶、γ-谷氨酰转移酶、碱性磷酸酶、白蛋白及Anali评分。
  • Anali评分不含钆和含钆识别无肝移植或肝硬化失代偿生存的c-statistic分别为0.89(95%CI 0.84-0.95)和0.75(95%CI 0.64-0.87)。
  • 多因素分析确定的独立预后因素为Anali评分和胆红素血症。
  • Anali评分的预后价值在外部队列中得到确认。

关键数值与推荐

  • Anali评分不含钆 =(1×肝内胆管扩张)+(2×形态异常)+(1×门静脉高压)。
  • Anali评分含钆 =(1×形态异常)+(1×实质强化不均匀)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC) has a variable, often progressive, course. Magnetic resonance cholangiography (MRC) is used in the diagnosis of PSC. Magnetic resonance risk scoring systems, called Anali without and with gadolinium, are used to predict disease progression, determined by radiologic factors. We aimed to assess the prognostic value of Anali scores in patients with PSC and validate our findings in a separate cohort. METHODS: We performed a retrospective study of patients with large-duct PSC (internal cohort, 119 patients in France; external cohort, 119 patients in Canada, Italy, and the United Kingdom). All the first-available MRC results were reviewed by 2 radiologists and the Anali scores were calculated as follows: Anali without gadolinium = (1× dilatation of intrahepatic bile ducts) + (2× dysmorphy) + (1× portal hypertension); Anali with gadolinium = (1× dysmorphy) + (1× parenchymal enhancement heterogeneity). The primary end point was survival without liver transplantation or cirrhosis decompensation. The prognostic value of Anali scores was assessed by Cox regression modeling. RESULTS: During a total of 549 patient-years for the internal cohort and 497 patient-years for the external cohort, we recorded 2 and 8 liver transplantations, 4 and 3 liver-related deaths, and 26 and 25 cirrhosis decompensations, respectively. In the univariate analysis, factors associated with survival without liver transplantation or cirrhosis decompensation in the internal cohort were as follows: serum levels of bilirubin, aspartate aminotransferase, alanine aminotransferase, γ-glutamyl transferase, alkaline phosphatase, albumin, and Anali scores. Anali scores without and with gadolinium identified patients' survival without liver transplantation or cirrhosis decompensation with a c-statistic of 0.89 (95% CI, 0.84-0.95) and 0.75 (95% CI, 0.64-0.87), respectively. Independent prognostic factors identified by multivariate analysis were Anali scores and bilirubinemia. The prognostic value of Anali scores was confirmed in the external cohort. CONCLUSIONS: In internal and external cohorts, we found that Anali scores, determined from MRC, were associated with outcomes of patients with PSC. These scores might be used as prognostic factors.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Lemoinne S, Cazzagon N, El Mouhadi S, et al. Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis. Clin Gastroenterol Hepatol. 2019. PMID: 30880273. doi:10.1016/j.cgh.2019.03.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。